TRIM24 and head and neck squamous cell carcinoma: The finding that the aberrant expression of TRIM24 correlates with the poor survival of patients with HNSCC is significant because it suggests TRIM24 may play an important biological role in the progression of HNSCC and be used as a biomarker to predict clinical outcome of patients with HNSCC.